BORTEZOMIB CIPLA 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG

Cipla Europe🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 6f98151c293ef6e1
Drug Cima Aemps Name: BORTEZOMIB CIPLA 3,5 MG POLVO PARA SOLUCION INYECTABLE EFG
Register Number: 85658
Holder Company Name: Cipla Europe
Marketing Company Name: Cipla Europe Nv Sucursal En Espana
Authorization Date: 2020-12-16
Dosage Form: POLVO PARA SOLUCIÓN INYECTABLE
Dose: 3.5 mg
Route Of Administration: VÍA INTRAVENOSA, VÍA SUBCUTÁNEA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Cipla Europe

BORTEZOMIB

3,5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Dec 16, 2020

Approval ID

6f98151c293ef6e1

Type

Standard